Abstract
For clinical evaluation, assessing amyloid deposition with PiB-PET is desirable without requiring MR acquisition and associated fusion/segmentation techniques. A useful clinical tool is to estimate PiB-PET against the brain surface, which is however challenging using PET alone because of the lack of structural information. We propose a method to generate such estimate, where multiple atlases are selected and combined with local weights in a Bayesian framework. Qualitative and quantitative comparison with and without MRI are presented. Using PET only, the average error on the brain surface was around 13% compared to MRI-dependant method.
MeSH terms
-
Algorithms
-
Alzheimer Disease / diagnostic imaging*
-
Alzheimer Disease / metabolism*
-
Amyloidogenic Proteins / metabolism*
-
Aniline Compounds
-
Bayes Theorem
-
Benzothiazoles*
-
Brain / diagnostic imaging*
-
Brain / metabolism*
-
Female
-
Humans
-
Image Enhancement / methods
-
Image Interpretation, Computer-Assisted / methods
-
Magnetic Resonance Imaging
-
Male
-
Pattern Recognition, Automated / methods
-
Positron-Emission Tomography / methods*
-
Radiopharmaceuticals
-
Reproducibility of Results
-
Sensitivity and Specificity
-
Subtraction Technique
-
Thiazoles
Substances
-
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
-
Amyloidogenic Proteins
-
Aniline Compounds
-
Benzothiazoles
-
Radiopharmaceuticals
-
Thiazoles